Plasmid selection in <it>Escherichia coli </it>using an endogenous essential gene marker

<p>Abstract</p> <p>Background</p> <p>Antibiotic resistance genes are widely used for selection of recombinant bacteria, but their use risks contributing to the spread of antibiotic resistance. In particular, the practice is inappropriate for some intrinsically resistant...

Full description

Bibliographic Details
Main Authors: Good Liam, Goh Shan
Format: Article
Language:English
Published: BMC 2008-08-01
Series:BMC Biotechnology
Online Access:http://www.biomedcentral.com/1472-6750/8/61
_version_ 1828463297557430272
author Good Liam
Goh Shan
author_facet Good Liam
Goh Shan
author_sort Good Liam
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Antibiotic resistance genes are widely used for selection of recombinant bacteria, but their use risks contributing to the spread of antibiotic resistance. In particular, the practice is inappropriate for some intrinsically resistant bacteria and in vaccine production, and costly for industrial scale production. Non-antibiotic systems are available, but require mutant host strains, defined media or expensive reagents. An unexplored concept is over-expression of a host essential gene to enable selection in the presence of a chemical inhibitor of the gene product. To test this idea in <it>E. coli</it>, we used the growth essential target gene <it>fabI </it>as the plasmid-borne marker and the biocide triclosan as the selective agent.</p> <p>Results</p> <p>The new cloning vector, pFab, enabled selection by triclosan at 1 μM. Interestingly, pFab out-performed the parent pUC19-ampicillin system in cell growth, plasmid stability and plasmid yield. Also, pFab was toxic to host cells in a way that was reversed by triclosan. Therefore, pFab and triclosan are toxic when used alone but in combination they enhance growth and plasmid production through a gene-inhibitor interaction.</p> <p>Conclusion</p> <p>The <it>fabI</it>-triclosan model system provides an alternative plasmid selection method based on essential gene over-expression, without the use of antibiotic-resistance genes and conventional antibiotics.</p>
first_indexed 2024-12-11T02:52:57Z
format Article
id doaj.art-b95b5559826140898091173078ccf60c
institution Directory Open Access Journal
issn 1472-6750
language English
last_indexed 2024-12-11T02:52:57Z
publishDate 2008-08-01
publisher BMC
record_format Article
series BMC Biotechnology
spelling doaj.art-b95b5559826140898091173078ccf60c2022-12-22T01:23:16ZengBMCBMC Biotechnology1472-67502008-08-01816110.1186/1472-6750-8-61Plasmid selection in <it>Escherichia coli </it>using an endogenous essential gene markerGood LiamGoh Shan<p>Abstract</p> <p>Background</p> <p>Antibiotic resistance genes are widely used for selection of recombinant bacteria, but their use risks contributing to the spread of antibiotic resistance. In particular, the practice is inappropriate for some intrinsically resistant bacteria and in vaccine production, and costly for industrial scale production. Non-antibiotic systems are available, but require mutant host strains, defined media or expensive reagents. An unexplored concept is over-expression of a host essential gene to enable selection in the presence of a chemical inhibitor of the gene product. To test this idea in <it>E. coli</it>, we used the growth essential target gene <it>fabI </it>as the plasmid-borne marker and the biocide triclosan as the selective agent.</p> <p>Results</p> <p>The new cloning vector, pFab, enabled selection by triclosan at 1 μM. Interestingly, pFab out-performed the parent pUC19-ampicillin system in cell growth, plasmid stability and plasmid yield. Also, pFab was toxic to host cells in a way that was reversed by triclosan. Therefore, pFab and triclosan are toxic when used alone but in combination they enhance growth and plasmid production through a gene-inhibitor interaction.</p> <p>Conclusion</p> <p>The <it>fabI</it>-triclosan model system provides an alternative plasmid selection method based on essential gene over-expression, without the use of antibiotic-resistance genes and conventional antibiotics.</p>http://www.biomedcentral.com/1472-6750/8/61
spellingShingle Good Liam
Goh Shan
Plasmid selection in <it>Escherichia coli </it>using an endogenous essential gene marker
BMC Biotechnology
title Plasmid selection in <it>Escherichia coli </it>using an endogenous essential gene marker
title_full Plasmid selection in <it>Escherichia coli </it>using an endogenous essential gene marker
title_fullStr Plasmid selection in <it>Escherichia coli </it>using an endogenous essential gene marker
title_full_unstemmed Plasmid selection in <it>Escherichia coli </it>using an endogenous essential gene marker
title_short Plasmid selection in <it>Escherichia coli </it>using an endogenous essential gene marker
title_sort plasmid selection in it escherichia coli it using an endogenous essential gene marker
url http://www.biomedcentral.com/1472-6750/8/61
work_keys_str_mv AT goodliam plasmidselectioninitescherichiacoliitusinganendogenousessentialgenemarker
AT gohshan plasmidselectioninitescherichiacoliitusinganendogenousessentialgenemarker